Cetera Investment Advisers bought a new stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 17,879 shares of the company's stock, valued at approximately $965,000. Cetera Investment Advisers owned about 0.19% of Semler Scientific at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Exchange Traded Concepts LLC grew its position in Semler Scientific by 345.8% in the 4th quarter. Exchange Traded Concepts LLC now owns 61,396 shares of the company's stock worth $3,315,000 after purchasing an additional 47,625 shares during the period. Deltec Asset Management LLC purchased a new position in shares of Semler Scientific in the 4th quarter worth $2,462,000. Principal Financial Group Inc. grew its holdings in shares of Semler Scientific by 633.1% in the fourth quarter. Principal Financial Group Inc. now owns 112,487 shares of the company's stock worth $6,074,000 after acquiring an additional 97,144 shares during the period. Sanctuary Advisors LLC grew its holdings in shares of Semler Scientific by 13.2% in the fourth quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company's stock worth $261,000 after acquiring an additional 584 shares during the period. Finally, Global Retirement Partners LLC increased its position in Semler Scientific by 62.5% during the fourth quarter. Global Retirement Partners LLC now owns 1,300 shares of the company's stock valued at $70,000 after acquiring an additional 500 shares during the last quarter. Institutional investors own 49.37% of the company's stock.
Semler Scientific Price Performance
Shares of SMLR traded down $1.24 on Thursday, reaching $40.08. The company's stock had a trading volume of 534,385 shares, compared to its average volume of 490,359. The stock's 50 day simple moving average is $36.15 and its two-hundred day simple moving average is $47.10. The stock has a market capitalization of $446.97 million, a P/E ratio of 8.16 and a beta of 1.33. Semler Scientific, Inc. has a 12-month low of $21.77 and a 12-month high of $81.56.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The business had revenue of $8.84 million for the quarter.
Wall Street Analyst Weigh In
Separately, Wall Street Zen cut Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd.
Check Out Our Latest Report on SMLR
About Semler Scientific
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
See Also
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
